Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired Triad Isotopes
Acquired_Solara_Active_Pharma_Sciences |
| gptkbp:awards |
Best Employer Award 2020
Excellence in Pharma Award 2021 |
| gptkbp:collaborations |
Academic Institutions
Research Organizations Healthcare_Providers |
| gptkbp:communityEngagement |
Educational Programs
Health Camps Skill_Development_Initiatives |
| gptkbp:employees |
Over 10,000
|
| gptkbp:financialPerformance |
Revenue Growth
R&D Investment Profit_Margins |
| gptkbp:founded |
1978
|
| gptkbp:founder |
gptkb:Shyam_S._Bhartia
|
| gptkbp:globalPresence |
Operations_in_Asia
Operations_in_Europe Operations_in_North_America |
| gptkbp:headquarters |
gptkb:Noida,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jubilant Pharmova
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
New_Drug_Formulations
Biologics_Development Novel_Delivery_Systems |
| gptkbp:market |
Approximately $1 billion
|
| gptkbp:marketSegment |
Biotechnology
Pharmaceuticals Diagnostics Nutraceuticals |
| gptkbp:partnerships |
Partnership with various biotech firms
|
| gptkbp:products |
Generic_Drugs
Active_Pharmaceutical_Ingredients_(APIs) |
| gptkbp:regulatoryCompliance |
WHO Prequalification
EMA_Approved FDA_Approved |
| gptkbp:researchFocus |
gptkb:Central_Nervous_System
Oncology Diabetes Cardiovascular |
| gptkbp:services |
Drug Development
Contract Manufacturing |
| gptkbp:stockSymbol |
JUBILANT
|
| gptkbp:subsidiary |
gptkb:Jubilant_Life_Sciences
gptkb:Jubilant_HollisterStier |
| gptkbp:sustainabilityInitiatives |
Waste Management Programs
Energy Efficiency Projects Green Chemistry Practices |
| gptkbp:website |
www.jubilantpharmova.com
|